Cardiol Therapeutics Inc., a late-stage life sciences company, has recently disclosed that it has submitted a preliminary short... The company's stock symbols are NASDAQ: CRDL and TSX: CRDL. They specialize in developing treatments for heart disease that focus on anti-inflammatory and anti-fibrotic solutions.